Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry
<p>Abstract</p> <p>Background</p> <p>Guidelines recommend an early initiation of aspirin treatment in patients with acute cerebral ischemia. Comparative studies on the best starting dose for initiating aspirin therapy to achieve a rapid antiplatelet effect do not exist....
Main Authors: | Overbeck Ursula, Neubauer Horst, Meves Saskia H, Endres Heinz G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/4/106 |
Similar Items
-
Comparison of antiplatelet activity of garlic tablets with cardio-protective dose of aspirin in healthy volunteers: a randomized clinical trial
by: Mojtaba Shafiekhani, et al.
Published: (2016-08-01) -
Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
by: Hamzah Khan, et al.
Published: (2020-10-01) -
Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
by: Hamzah Khan, et al.
Published: (2020-10-01) -
Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications
by: Katalin Koltai, et al.
Published: (2017-08-01) -
Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin
by: Marco Tescione, et al.
Published: (2021-03-01)